Virchows Archiv

, Volume 452, Issue 2, pp 221–227

Systemic Erdheim–Chester disease

  • Brendan Craig Dickson
  • Vaijayanti Pethe
  • Catherine Tse-Shing Chung
  • David John Charles Howarth
  • Juan Manuel Bilbao
  • Victor Lodovico Fornasier
  • Catherine Joanne Streutker
  • Linda Marilyn Sugar
  • Bharati Bapat
Case Report

Abstract

Erdheim–Chester disease is a rare xanthomatosis that may present with characteristic radiologic and histologic features. There have been conflicting reports regarding the nature of this process, including whether it represents a reactive or neoplastic lesion. We present the clinical histories, pathologic findings, and an analysis of clonality using the HUMARA assay in two patients diagnosed with Erdheim–Chester disease. One case has previously been documented in the literature. Histologically, both cases demonstrated sheets of foamy xanthomatous histiocytes with widespread infiltration of the viscera. These regions were punctuated by variable amounts of inflammation, including lymphocytes, plasma cells, and occasional Touton-type giant cells. The histiocytes were immunoreactive for CD68 and CD163; they did not stain with S100 or CD1a. One case was found to be monoclonal; however, the second case had extensive DNA degradation; thus, clonality could not be assessed. In addition to contributing an additional report of this rare disease to the literature, we demonstrate the histiocytes to express CD163, thereby further supporting a monocyte/macrophage basis. Moreover, in confirming clonality, our observations lend additional evidence to the view that Erdheim–Chester disease represents a neoplastic process.

Keywords

Erdheim–Chester disease Clonality HUMARA assay Neoplasm Xanthomatosis Case report CD163 

References

  1. 1.
    Alexander AS, Turner R, Uniate L, Pearcy RG (2005) Xanthoma disseminatum: a case report and literature review. Br J Radiol 78:153–157CrossRefPubMedGoogle Scholar
  2. 2.
    Al-Quran S, Reith J, Bradley J, Rimsza L (2002) Erdheim–Chester disease: case report, PCR-based analysis of clonality, and review of literature. Mod Pathol 15:666–672CrossRefPubMedGoogle Scholar
  3. 3.
    Barnes PJ, Foyle A, Hache KA, Langley RG, Burrell S, Juskevicius R (2005) Erdheim–Chester disease of the breast: a case report and review of the literature. Breast J 11:462–467CrossRefPubMedGoogle Scholar
  4. 4.
    Boudewijns M, van Dongen JJ, Langerak AW (2007) The human androgen receptor X-chromosome inactivation assay for clonality diagnostics of natural killer cell proliferations. J Mol Diagn 9:337–344CrossRefPubMedGoogle Scholar
  5. 5.
    Caputo R, Veraldi S, Grimalt R, Gianotti R, Tosti A, Varotti C, de Kaminsky AR (1995) The various clinical patterns of xanthoma disseminatum. Considerations on seven cases and review of the literature. Dermatology 190:19–24PubMedCrossRefGoogle Scholar
  6. 6.
    Chester W (1930) Über lipoidgranulomatose. Virchows Arch Pathol Anat 279:561–602CrossRefGoogle Scholar
  7. 7.
    Chetritt J, Paradis V, Dargere D, Adle-Biassette H, Maurage CA, Mussini JM, Vital A, Wechsler J, Bedossa P (1999) Chester–Erdheim disease: a neoplastic disorder. Hum Pathol 30:1093–1096CrossRefPubMedGoogle Scholar
  8. 8.
    Cruz AA, de Alencar VM, Falcao MF, Elias J Jr., Chahud F (2006) Association between Erdheim–Chester disease, Hashimoto thyroiditis, and familial thrombocytopenia. Ophthal Plast Reconstr Surg 22:60–62CrossRefPubMedGoogle Scholar
  9. 9.
    Curgunlu A, Karter Y, Ozturk A (2003) Erdheim–Chester disease: a rare cause of paraplegia. Eur J Intern Med 14:53–55CrossRefPubMedGoogle Scholar
  10. 10.
    Eble JN, Rosenberg AE, Young RH (1994) Retroperitoneal xanthogranuloma in a patient with Erdheim–Chester disease. Am J Surg Pathol 18:843–848PubMedCrossRefGoogle Scholar
  11. 11.
    Egan AJ, Boardman LA, Tazelaar HD, Swensen SJ, Jett JR, Yousem SA, Myers JL (1999) Erdheim–Chester disease: clinical, radiologic, and histopathologic findings in five patients with interstitial lung disease. Am J Surg Pathol 23:17–26CrossRefPubMedGoogle Scholar
  12. 12.
    Egeler RM, Pritchard J, Gadner H, D’Angio GJ (1995) An international histiocytic language. Blood 85:2281–2282PubMedGoogle Scholar
  13. 13.
    Favara BE, Feller AC, Pauli M, Jaffe ES, Weiss LM, Arico M, Bucsky P, Egeler RM, Elinder G, Gadner H (1997) Contemporary classification of histiocytic disorders. The WHO committee on histiocytic/reticulum cell proliferations. Reclassification working group of the histiocyte society. Med Pediatr Oncol 29:157–166CrossRefPubMedGoogle Scholar
  14. 14.
    Gauthier V, Cauchon R (1958) Retroperitoneal xanthogranuloma: 2 cases. Laval Med 26:316–337PubMedGoogle Scholar
  15. 15.
    Hisanaga Y, Akaike Y, Kuroda K (2004) Xanthoma disseminatum with large plaques confined to the back, pulmonary involvement and multiple intestinal xanthomas. Dermatology 208:164–166CrossRefPubMedGoogle Scholar
  16. 16.
    Jaffe HL (1972) Lipid (cholesterol) granulomatosis. Metabolic, degenerative and inflammatory diseases of bones and joints. Lea & Fibiger, Philadelphia, pp 535 –541Google Scholar
  17. 17.
    Jaffe R (2004) Dendritic histiocytoses: an update. Companion meeting: society for hematopathology (USCAP 2004). Vancouver, British ColumbiaGoogle Scholar
  18. 18.
    Khandpur S, Manchanda Y, Sharma VK, Singh MK, Tandon N (2003) Rare association of xanthoma disseminatum with skeletal involvement. Australas J Dermatol 44:190–193CrossRefPubMedGoogle Scholar
  19. 19.
    Kovacs K, Bilbao JM, Fornasier VL, Horvath E (2004) Pituitary pathology in Erdheim–Chester disease. Endocr Pathol 15:159–166CrossRefPubMedGoogle Scholar
  20. 20.
    Majno G, Joris I (2004) Cells, tissues, and disease: principles of general pathology, 2nd edn. Oxford University Press, New York, p 1040Google Scholar
  21. 21.
    Oberling C (1935) Retroperitoneal xanthogranuloma. Am J Cancer 23:477–489Google Scholar
  22. 22.
    QIAGEN (2003) QIAamp DNA Mini Kit and QIAamp DNA Blood Mini Kit HandbookGoogle Scholar
  23. 23.
    Rush WL, Andriko JA, Galateau-Salle F, Brambilla E, Brambilla C, Ziany-bey I, Rosado-de-Christenson ML, Travis WD (2000) Pulmonary pathology of Erdheim–Chester disease. Mod Pathol 13:747–754CrossRefPubMedGoogle Scholar
  24. 24.
    Simpson FG, Robinson PJ, Hardy GJ, Losowsky MS (1979) Erdheim–Chester disease associated with retroperitoneal xanthogranuloma. Br J Radiol 52:232–235PubMedCrossRefGoogle Scholar
  25. 25.
    Sivak-Callcott JA, Lim WK, Seah LL, Oestreicher J, Rossman D, Nijhawan N, Rootman J, White V, Williams HJ, Chang WW, DiBartolomeo A, Howarth D (2005) Xanthogranulomatous disease in the lacrimal gland. Br J Ophthalmol 89:1375–1377CrossRefPubMedGoogle Scholar
  26. 26.
    Sorensen EW (1964) Hyperlipidemia. A report of an unusual case complicated by bone-lesions, macrocytic anaemia and leukemoid bone marrow. Acta Med Scand 175:207–214PubMedCrossRefGoogle Scholar
  27. 27.
    Vencio EF, Jenkins RB, Schiller JL, Huynh TV, Wenger DD, Inwards CY, Oliveira AM (2007) Clonal cytogenetic abnormalities in Erdheim–Chester disease. Am J Surg Pathol 31:319–321CrossRefPubMedGoogle Scholar
  28. 28.
    Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, Wechsler J, Brun B, Remy M, Wallaert B, Petit H, Grimaldi A, Wechsler B, Godeau P (1996) Erdheim–Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine (Baltimore) 75:157–169CrossRefGoogle Scholar
  29. 29.
    Vinh TN, Sweet DE (2002) Erdheim–Chester disease. In: Fletcher CDM, Unni KK, Mertens F (eds) Pathology and genetics of tumours of soft tissue and bone. IARC, Lyon, p 347Google Scholar
  30. 30.
    Vos JA, Abbondanzo SL, Barekman CL, Andriko JW, Miettinen M, Aguilera NS (2005) Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163. Mod Pathol 18:693–704CrossRefPubMedGoogle Scholar
  31. 31.
    Wang L, Zhu H (2006) Clonal analysis of palmar fibromatosis: a study whether palmar fibromatosis is a real tumor. J Transl Med 4:21CrossRefPubMedGoogle Scholar
  32. 32.
    West RB, Rubin BP, Miller MA, Subramanian S, Kaygusuz G, Montgomery K, Zhu S, Marinelli RJ, De Luca A, Downs-Kelly E, Goldblum JR, Corless CL, Brown PO, Gilks CB, Nielsen TO, Huntsman D, van de Rijn M (2006) A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci U S A 103:690–695CrossRefPubMedGoogle Scholar
  33. 33.
    Willman CL, Busque L, Griffith BB, Favara BE, McClain KL, Duncan MH, Gilliland DG (1994) Langerhans’-cell histiocytosis (histiocytosis X)—a clonal proliferative disease. N Engl J Med 331:154–160CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Brendan Craig Dickson
    • 1
    • 2
  • Vaijayanti Pethe
    • 1
    • 2
    • 3
  • Catherine Tse-Shing Chung
    • 1
    • 2
  • David John Charles Howarth
    • 1
    • 2
  • Juan Manuel Bilbao
    • 2
    • 5
  • Victor Lodovico Fornasier
    • 2
    • 4
  • Catherine Joanne Streutker
    • 2
    • 4
  • Linda Marilyn Sugar
    • 2
    • 5
  • Bharati Bapat
    • 1
    • 2
    • 3
    • 6
  1. 1.Department of Pathology and Laboratory MedicineMount Sinai HospitalTorontoCanada
  2. 2.Department of Laboratory Medicine and PathobiologyUniversity of TorontoTorontoCanada
  3. 3.Samuel Lunenfeld Research InstituteMount Sinai HospitalTorontoCanada
  4. 4.Division of PathologySt. Michael’s HospitalTorontoCanada
  5. 5.Department of Anatomic PathologySunnybrook Health Science CenterTorontoCanada
  6. 6.Department of Pathology and Laboratory Medicine, Samuel Lunenfeld Research InstituteMount Sinai HospitalTorontoCanada

Personalised recommendations